Work

Fed and Fasted Single-dose Assessment of Bioequivalence of Dapagliflozin and Metformin Extended-release Fixed-dose Combination Tablets Relative to Single-component Dapagliflozin and Metformin Extended-release Tablets in Healthy Subjects

Year: 2015

Type: article

Study design: Clinical Trial

Source: Clinical Therapeutics

DOI: 10.1016/j.clinthera.2015.11.010

Authors: David W. Boulton, Ming Chang, Steven C. Griffen, Catia Kitaura, Susan Lubin, Allyson Pollack, Frank LaCreta

Institutions: AstraZeneca (United States), Bristol-Myers Squibb (United States), Breakthrough T1D

Language: English

Topic: Diabetes Treatment and Management

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Bristol-Myers Squibb, AstraZeneca

OpenAlex ID: W2194419056

FWCI: 1.159

Cites: 20

Cited by: 14

Related to: 10